Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Aug;8(8):669-670.
doi: 10.1016/S2213-8587(20)30223-0.

Management of diabetes in patients with COVID-19 - Authors' reply

Stefan R Bornstein  1 , Paul Zimmet  2 , Francesco Rubino  3 , Barbara Ludwig  4
Affiliations
Comment

Management of diabetes in patients with COVID-19 - Authors' reply

Stefan R Bornstein et al. Lancet Diabetes Endocrinol. 2020 Aug.
No abstract available

PubMed Disclaimer

Comment on

  • Practical recommendations for the management of diabetes in patients with COVID-19.
    Bornstein SR, Rubino F, Khunti K, Mingrone G, Hopkins D, Birkenfeld AL, Boehm B, Amiel S, Holt RI, Skyler JS, DeVries JH, Renard E, Eckel RH, Zimmet P, Alberti KG, Vidal J, Geloneze B, Chan JC, Ji L, Ludwig B. Bornstein SR, et al. Lancet Diabetes Endocrinol. 2020 Jun;8(6):546-550. doi: 10.1016/S2213-8587(20)30152-2. Epub 2020 Apr 23. Lancet Diabetes Endocrinol. 2020. PMID: 32334646 Free PMC article. Review.
  • Management of diabetes in patients with COVID-19.
    Lalau JD, Al-Salameh A. Lalau JD, et al. Lancet Diabetes Endocrinol. 2020 Aug;8(8):666-667. doi: 10.1016/S2213-8587(20)30231-X. Lancet Diabetes Endocrinol. 2020. PMID: 32707108 Free PMC article. No abstract available.
  • Management of diabetes in patients with COVID-19.
    Mukherjee JJ, Gangopadhyay KK, Ray S. Mukherjee JJ, et al. Lancet Diabetes Endocrinol. 2020 Aug;8(8):666. doi: 10.1016/S2213-8587(20)30226-6. Lancet Diabetes Endocrinol. 2020. PMID: 32707109 Free PMC article. No abstract available.
  • Management of diabetes in patients with COVID-19.
    Munshi MN, Sy SL. Munshi MN, et al. Lancet Diabetes Endocrinol. 2020 Aug;8(8):667-668. doi: 10.1016/S2213-8587(20)30227-8. Lancet Diabetes Endocrinol. 2020. PMID: 32707110 Free PMC article. No abstract available.
  • Management of diabetes in patients with COVID-19.
    Li A, Harris S, Kariyawasam D, Patel DC, Thomas SM. Li A, et al. Lancet Diabetes Endocrinol. 2020 Aug;8(8):668. doi: 10.1016/S2213-8587(20)30234-5. Lancet Diabetes Endocrinol. 2020. PMID: 32707111 Free PMC article. No abstract available.
  • Management of diabetes in patients with COVID-19.
    Khalangot M. Khalangot M. Lancet Diabetes Endocrinol. 2020 Aug;8(8):669. doi: 10.1016/S2213-8587(20)30235-7. Lancet Diabetes Endocrinol. 2020. PMID: 32707112 Free PMC article. No abstract available.

References

    1. Bornstein SR, Rubino F, Khunti K. Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol. 2020;8:546–550. - PMC - PubMed
    1. Ciavarella C, Motta I, Valente S, Pasquinelli G. Pharmacological (or synthetic) and nutritional agonists of PPAR-γ as candidates for cytokine storm modulation in COVID-19 disease. Molecules. 2020;25 - PMC - PubMed
    1. Pinto LC, Bertoluci MC. Type 2 diabetes as a major risk factor for COVID-19 severity: a meta-analysis. Arch Endocrinol Metab. 2020;64:199–200. - PMC - PubMed
    1. Bornstein SR, Dalan R, Hopkins D, Mingrone G, Boehm BO. Endocrine and metabolic link to coronavirus infection. Nat Rev Endocrinol. 2020;16:297–298. - PMC - PubMed
    1. de Simone G. Position statement of the ESC Council on hypertension on ACE-inhibitors and angiotensin receptor blockers. March 12, 2020. https://www.escardio.org/Councils/Council-on-Hypertension-%28CHT%29/News...